CCCC | C4 TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$3.21
-$0.16 (-4.75%)

C4 Therapeutics (CCCC) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Mar 2026, but the two have been closing on each other and a death cross is projected within 10 bars. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
below both $3.21 vs 50 $3.31 / 200 $3.21
Projection
Death cross projected in 5 bars
Test
No active test
Last cross
Golden cross 10 Mar 2026 ยท projected 23 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $3.37 vs 50 $3.05 / 200 $3.82
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
between the two $3.21 vs 50 $3.06 / 200 $3.62
Projection
No cross projected
Test
No active test
Last cross
Death cross 22 Sep 2026 ยท projected 25 bars out

Cross history

18
crosses on record since 2021
9 golden9 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
22 Sep 2026Death4-hour25 bars outNot tested
10 Mar 2026Golden moderatedaily23 bars outNot tested
9 Mar 2026Golden4-hour22 bars outNot tested
13 Feb 2026Death steepdaily29 bars out3 bar cross test
18 Dec 2025Death4-hour28 bars outNot tested

About CCCC

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$7.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.